EligibleTrials

Clinical trials recruiting for Transthyretin Amyloid Cardiomyopathy (ATTR-CM)

3
Recruiting trials
28
US states with sites
21
Countries
33%
Accept healthy volunteers

Phase breakdown

Phase 3 1Not applicable 2

Drugs and treatments being studied

InterventionTrials
Acoramidis (356 mg film-coated tablets)1
NNC6019-00011

Where trials are recruiting (top US states)

StateRecruiting trials
Arizona1
California1
Connecticut1
District of Columbia1
Florida1
Georgia1
Hawaii1
Illinois1
Indiana1
Louisiana1
Maryland1
Massachusetts1

Top cities

Abington, Pennsylvania 1Ann Arbor, Michigan 1Austin, Texas 1Baltimore, Maryland 1Boston, Massachusetts 1Chicago, Illinois 1Cincinnati, Ohio 1Cleveland, Ohio 1Columbus, Ohio 1Dallas, Texas 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) often also study these conditions. Each links to its own recruiting-trial list.

Heart failure 1021

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Transthyretin Amyloid Cardiomyopathy (ATTR-CM) trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.